Start the conversation
People who know how to invest in the biggest pharma profits play the most expensive medicines on the market, known as "orphan drugs."
In the United States, an orphan drug treats a disease that affects fewer than 7 in 10,000 people. In the EU, it's fewer than 5 in 10,000 people. The diseases are chronic, brutal, and life-threatening.